Michael F. Burgess - 01 Jun 2022 Form 4 Insider Report for SpringWorks Therapeutics, Inc. (SWTX)

Role
Head of Research & Development
Signature
/s/ Francis I. Perier, Jr. as Attorney-in Fact
Issuer symbol
SWTX
Transactions as of
01 Jun 2022
Transactions value $
-$52,398
Form type
4
Date filed
05 Jul 2022, 17:29
Previous filing
10 Jan 2022
Next filing
13 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWTX Common Stock Tax liability -$52.4K -2.67K -6.19% $19.61 40.5K 01 Jun 2022 Direct F1
transaction SWTX Common Stock Award $0 +12.2K +30.08% $0.00 52.7K 30 Jun 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock awards and does not represent a sale by the Reporting Person.
F2 Represents restricted stock awards, which became fully vested on June 30, 2022.